2019 Inhibition in the CNS Gordon Research Conference and Gordon Research Seminar

2019年中枢神经系统戈登研究会议和戈登研究研讨会的抑制

• 批准号: 9750981
• 负责人: IVAN SOLTESZ
• 金额: $ 2万
• 依托单位: GORDON RESEARCH CONFERENCES
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-04-01 至 2019-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9750981
• 关键词: Address; Adult; Affect; Anxiety; Area; Attention; Axon; Benzodiazepines; Brain; Brain Diseases; Cell Communication; Central Nervous System Diseases; Cognition; Collaborations; Communities; Country; Development; Disease; Educational Status; Ensure; Epilepsy; Europe; Exposure to; Face; Functional disorder; Future; Gender; Geography; Goals; Growth; Health; Hour; International; Internationality; Interneurons; Knowledge; Maine; Mediating; Mental Depression; Mental disorders; Mentors; Modeling; Molecular; National Institute of Child Health and Human Development; National Institute of Neurological Disorders and Stroke; Nature; Nervous System Physiology; Neuraxis; Neuroglia; Neurons; Neurotransmitters; Participant; Pathologic; Postdoctoral Fellow; Request for Proposals; Research; Research Personnel; Resolution; Rivers; Role; Schizophrenia; Science; Scientist; Series; Signal Transduction; Students; Synapses; Training; Woman; Work; autism spectrum disorder; brain abnormalities; career; gamma-Aminobutyric Acid; graduate student; human disease; innovation; interest; meetings; myelination; nervous system disorder; neuronal circuitry; neurosteroids; neurotransmission; posters; programs; receptor; spatiotemporal; symposium; synaptogenesis; targeted treatment; training opportunity; transmission process

Project Summary The 2019 Gordon Research Conference (GRC) on Inhibition in the Central Nervous System will be held at the Grand Summit Hotel at Sunday River, Newry, Maine, USA, on July 7-12, 2019. This international research conference has been held every 2 years since 2005 as part of the GRC conference series. It will be preceded on July 6 -7, 2019, as in previous editions, by the Gordon Research Seminar (GRS), which is reserved for graduate students and postdocs in order to give them an introduction to the main topics of the GRC. Inhibition, mediated primarily by the neurotransmitter GABA, regulates all aspects of central nervous system (CNS) function and represents a major target for therapeutics. The scientific community working on inhibitory neurotransmission is broad and very dynamic. This GRC provides a major forum bringing together leaders in the field along with rising new stars among early-career investigators. The goal of this meeting is to increase our understanding of the molecular, synaptic and network mechanisms contributing to the critical role of inhibitory neurotransmission in normal and abnormal CNS function. To achieve this goal, the meeting will pursue specific aims that include dissemination of the latest discoveries about inhibition in brain function and dysfunction, promotion of diversity and collaboration within the field, and advancement of the training of graduate students and postdoctoral fellows. These aims will be met by convening 34 world-class speakers and 9 discussion leaders actively working in diverse areas of inhibition from 11 different countries across 3 continents (25 from the US; 20 women), ensuring internationality and diversity. The GRC will accommodate up to 200 participants at a five-day conference in an isolated setting. The health relatedness of this application is that discussions at the Inhibition in the CNS GRC/GRS meetings will define the questions that require experimental resolution in areas related to cognition, development, and a variety of neurological and psychiatric disorders that involve dysregulated inhibition including autism, epilepsy, schizophrenia, anxiety, depression and other diseases. Taken together, it is expected that the scientific discussions, research talks, poster sessions, and various informal interactions between the diverse participants of this conference will advance our understanding of fundamental mechanisms underlying in CNS function and human disease.

项目摘要 2019年戈登中枢神经系统抑制研究会议(GRC)将于 2019年7月7日至12日，位于美国缅因州纽里市周日河畔的Grand Summit酒店。这项国际研究 自2005年以来，作为GRC会议系列的一部分，会议每两年举行一次。它将被放在前面 2019年7月6日至7日，与前几届一样，由戈登研究研讨会(GRS)主办，该研讨会为 研究生和博士后，以便向他们介绍GRC的主要主题。 抑制主要由神经递质GABA介导，调节中枢神经系统的各个方面。 (中枢神经系统)的功能，是治疗学的主要靶点。致力于抑制的科学界 神经传递是广泛的，非常动态的。GRC提供了一个重要的论坛，将各国领导人聚集在一起 该领域以及职业生涯早期研究人员中冉冉升起的新星。这次会议的目标是增加 我们对分子、突触和网络机制的理解有助于 中枢神经系统功能正常和异常时的神经传递抑制。为实现这一目标，会议将 追求特定的目标，包括传播关于大脑功能抑制的最新发现 和功能障碍，促进外地内的多样性和协作，以及推进培训 研究生和博士后研究员。这些目标将通过召集34位世界级演讲者来实现 来自11个不同国家的9位讨论领袖在不同的抑制领域积极工作，涉及3个国家 各大洲(25名来自美国，20名女性)，确保国际性和多样性。GRC将容纳最多 在与世隔绝的环境下举行的为期五天的会议上向200名与会者发表了讲话。此应用程序与健康相关的是 在CNS GRC/GRS会议上的禁止讨论将定义需要 在与认知、发展和各种神经学和神经学相关领域的实验分辨率 包括自闭症、癫痫、精神分裂症、焦虑、 抑郁症和其他疾病。综上所述，预计科学讨论，研究会谈， 海报会议，以及本次会议不同与会者之间的各种非正式互动将 促进我们对中枢神经系统功能和人类疾病潜在的基本机制的理解。